Ultrasound-enhanced drug delivery for cancer

Expert Opinion on Drug Delivery

Volumn 9, Issue 12, 2012, Pages 1525-1538

  Mo, Steven ^a   Coussios, Constantin C ^a   Seymour, Len ^a   Carlisle, Robert ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adenovirus; Cancer; Cavitation; Ultrasound therapy; Virotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; ECHO CONTRAST MEDIUM; EPIRUBICIN; HERPES SIMPLEX THYMIDINE KINASE; LIPOSOME; LUCIFERASE; SMALL INTERFERING RNA; THERMOSENSITIVE LIPOSOME; THROMBIN; THYMIDINE KINASE; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; CELL MEMBRANE PERMEABILITY; DRUG DELIVERY SYSTEM; DRUG EXTRAVASATION; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; MICROBUBBLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; REVIEW; RNA INTERFERENCE; SAFETY; SONOPORATION; SUICIDE GENE; THERMODYNAMICS; ULTRASOUND; VIROTHERAPY;

ACOUSTICS; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HIGH-ENERGY SHOCK WAVES; HUMANS; NANOPARTICLES; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; ULTRASONIC THERAPY;

EID: 84869767821     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.739603     Document Type: Review

References (102)

1. Ter Haar G, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 2007;23(2):89-104 (Pubitemid 46404248)
2. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005;5(4):321-7 (Pubitemid 40488637)
3. Zeng M, Liu X, Liu Y, et al. Torsional ultrasound modality for hard nucleus phacoemulsification cataract extraction. Br J Ophthalmol 2008;92(8):1092-6
4. Sokolov DL, Bailey MR, Crum LA. Dual-pulse lithotripter accelerates stone fragmentation and reduces cell lysis in vitro. Ultrasound Med Biol 2003;29(7):1045-52 (Pubitemid 36871735)
5. Reher P, Elbeshir ENI, Harvey W, et al. The stimulation of bone formation in vitro by therapeutic ultrasound. Ultrasound Med Biol 1997;23(8):1251-8 (Pubitemid 27452785)
6. McDannold N, Vykhodtseva N, Hynynen K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 2008;34(5):834-40 (Pubitemid 351608039)
7. Dromi S, Frenkel V, Luk A, et al. Pulsed-High Intensity Focused Ultrasound and Low Temperature-Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect. Clin Cancer Res 2007;13(9):2722-7 (Pubitemid 46788041)
8. Coussios CC, Roy RA. Applications of acoustics and cavitation to noninvasive therapy and drug delivery. Annu Rev Fluid Mech 2008;40:395-420 (Pubitemid 351234706)
9. Datta S, Coussios CC, McAdory LE, et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol 2006;32(8):1257-67 (Pubitemid 44093792)
10. Okita M, Nakano J, Kataoka H, et al. Effects of therapeutic ultrasound on joint mobility and collagen fibril arrangement in the endomysium of immobilized rat soleus muscle. Ultrasound Med Biol 2009;35(2):237-44
11. Watson KD, Lai CY, Qin S, et al. Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition (EMT) tumors. Cancer Res 2012;72:1485-93
12. Ferrara KW. Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev 2008;60(10):1097-102
13. Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng 2004;6:229-48 (Pubitemid 39209498)
14. Stride E, Coussios C. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proc Inst Mech Eng H 2010;224(2):171-328
15. Tachibana K, Tachibana S. The use of ultrasound for drug delivery. Echocardiography 2001;18(4):323-8 (Pubitemid 32579095)
16. Schneider M. Characteristics of Sono Vue. Echocardiography 1999;16:743-6
17. Kabalnov A, Klein D, Pelura T, et al. Dissolution of multicomponent microbubbles in the bloodstream. 1. Theory. Ultrasound Med Biol 1998;24(5):739-49 (Pubitemid 28285210)
18. Gyongy M, Coussios CC. Passive spatial mapping of inertial cavitation during HIFU exposure. IEEE Trans Biomed Eng 2010;57(1):48-56
19. Jensen CR, Ritchie RW, Gyongy M, et al. Spatiotemporal Monitoring of High-Intensity Focused Ultrasound Therapy with Passive Acoustic Mapping. Radiology 2012;262(1):252-61
20. Hill CR, Bamber JC, Ter Haar G. Physical principles of medical ultrasonics. J Acoust Soc Am 2005;117:15
21. Tho P, Manasseh R, Ooi A. Cavitation microstreaming patterns in single and multiple bubble systems. J Fluid Mech 2007;576:191
22. Brujan E, Ikeda T, Matsumoto Y. Jet formation and shock wave emission during collapse of ultrasound-induced cavitation bubbles and their role in the therapeutic applications of high-intensity focused ultrasound. Phys Med Biol 2005;50:4797
23. Pitt WG, Husseini GA, Staples BJ. Ultrasonic drug delivery-a general review. Expert Opin Drug Deliv 2004;1(1):37-56 (Pubitemid 40297955)
24. Dayton P, Klibanov A, Brandenburger G, Ferrara K. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol 1999;25(8):1195-201 (Pubitemid 29465793)
25. Nelson JL, Roeder BL, Carmen JC, et al. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res 2002;62(24):7280
26. Klibanov AL, Shevchenko TI, Raju BI, et al. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. J Control Release 2010;148(1):13-17
27. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007;99(14):1095-106 (Pubitemid 47241394)
28. Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000;101(22):2554-6 (Pubitemid 30350631)
29. Lawrie A, Brisken A, Francis S, et al. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000;7(23):2023-7 (Pubitemid 32036768)
30. Mason TJ. Therapeutic ultrasound an overview. Ultrason Sonochem 2011;18(4):847-52
31. van Wamel A, Bouakaz A, Bernard B, et al. Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics 2004;42(1):903-6
32. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Dis 2005;4(3):255-60 (Pubitemid 40372559)
33. Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9(6):372
34. Harada Y, Ogawa K, Irie Y, et al. Ultrasound activation of TiO 2 in melanoma tumors. J Control Release 2011;149(2):190-5
35. Bazan-Peregrino M, Arvanitis CD, Rifai B, et al. Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model. J Control Rel 2012;157(2):235-42
36. Miller DL, Pislaru SV, Greenleaf JF. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 2002;27(1):115-34 (Pubitemid 36553831)
37. Mo R, Lin S, Wang G, et al. Preliminary in vitro study of ultrasound sonoporation cell labeling with superparamagnetic iron oxide particles for MRI cell tracking. In: 2008: IEEE; 2008. p. 367-70
38. Miller DL, Bao S, Gies RA, Thrall BD. Ultrasonic enhancement of gene transfection in murine melanoma tumors. Ultrasound Med Biol 1999;25(9):1425-30
39. Yuan F, Dellian M, Fukumura D, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995;55(17):3752
40. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Nat Acad Sci 1998;95(8):4607
41. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156(4):1363-80 (Pubitemid 30660013)
42. Willmann JK, Cheng Z, Davis C, et al. Targeted Microbubbles for Imaging Tumor Angiogenesis: assessment of Whole-Body Biodistribution with Dynamic Micro-PET in Mice1. Radiology 2008;249(1):212-19
43. Sirsi S, Feshitan J, Kwan J, et al. Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol 2010;36(6):935-48
44. Rapoport NY, Kennedy AM, Shea JE, et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009;138(3):268-76
45. Seymour L. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 1992;9(2):135
46. g Gabizon A, Catane R, Uziely B, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994;54(4):987
47. Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 2009;30(11):592-9
48. Koch S, Pohl P, Cobet U, Rainov NG. Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects. Ultrasound Med Biol 2000;26(5):897-903 (Pubitemid 30609606)
49. Evjen TJ, Nilssen EA, Rognvaldsson S, et al. Distearoylphosphatidylethanolaminebased liposomes for ultrasound-mediated drug delivery. Eur J Pharm Biopharm 2010;75(3):327-33
50. Evjen TJ, Nilssen EA, Barnert S, et al. Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine. Eur J Pharm Sci 2011;42(4):380-6
51. Huang SL. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev 2008;60(10):1167-76
52. Huang SL, Hamilton AJ, Pozharski E, et al. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol 2002;28(3):339-48 (Pubitemid 34308914)
53. Huang SL, MacDonald RC. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta 2004;1665(1):134-41 (Pubitemid 39303578)
54. Weinstein JN, Magin RL, Cysyk RL, Zaharko DS. Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate. Cancer Res 1980;40(5):1388
55. Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000;60(24):6950
56. Frenkel V, Etherington A, Greene M, et al. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad Radiol 2006;13(4):469-79
57. Negishi Y, Omata D, Iijima H, et al. Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound. Mol Pharm 2010;7(1):217-26
58. Suzuki R, Takizawa T, Negishi Y, et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 2007;117(1):130-6 (Pubitemid 46161862)
59. Alkan Onyuksel H, Demos SM, Lanza GM, et al. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 1996;85(5):486-90 (Pubitemid 26150981)
60. Suzuki R, Takizawa T, Negishi Y, et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release 2008;125(2):137-44 (Pubitemid 350299602)
61. Kheirolomoom A, Dayton PA, Lum AFH, et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release 2007;118(3):275-84 (Pubitemid 46441545)
62. Larina IV, Evers BM, Ashitkov TV, et al. Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation. Technol Cancer Res Treat 2005;4(2):217
63. Wagstaffe SJ, Arora M, Coussios CC, Schiffter HA. Sonosensitive nanoparticle formulations for cavitation-mediated ultrasonic enhancement of local drug delivery. Material Research Society Symposium Proceeding. 2011; p. 1316, DOI: 10.1557/opl.2011.323
64. Gao Z, Kennedy AM, Christensen DA, Rapoport NY. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008;48(4):260-70
65. Wang Y, Li X, Zhou Y, et al. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. Int J Pharm 2010;384(1-2):148-53
66. Lattin J, Belnap D, Pitt W. Formation of eLiposomes as a drug delivery vehicle. Colloids Surf B Biointerfaces 2012;89:93-100
67. Sheeran PS, Luois S, Dayton PA, Matsunaga TO. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir 2011;27(17):10412-20
68. Yu T, Huang X, Hu K, et al. Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure. Ultrason Sonochem 2004;11(5):287-91 (Pubitemid 38648979)
69. Unger EC, McCREERY TP, Sweitzer RH, et al. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 1998;33(12):886
70. Tartis MS, McCallan J, Lum AFH, et al. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 2006;32(11):1771-80 (Pubitemid 44716573)
71. Wan CPL, Jackson JK, Pirmoradi FN, et al. Increased accumulation and retention of micellar paclitaxel in drug-sensitive and p-glycoprotein-expressing cell lines following ultrasound exposure. Ultrasound Med Biol 2012;38(5):736-44
72. Tachibana K, Uchida T, Tamura K, et al. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett 2000;149(1):189-94 (Pubitemid 30100575)
73. Liu HL, Hua MY, Yang HW, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Pro Nat Academy Sci 2010;107(34):15205-10
74. Senderoff RI, Sheu MT, Sokoloski TD. Fibrin based drug delivery systems. PDA J Pharm Sci Technol 1991;45(1):2-6
75. Fabiilli ML, Lee JA, Kripfgans OD, et al. The release of thrombin, using acoustic droplet vaporization (ADV), from perfluoropentane double emulsions. In: 2010: IEEE; 2010. p. 107-7
76. Glover DJ, Lipps HJ, Jans DA. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet 2005;6(4):299-310 (Pubitemid 40469049)
77. Arvanitis CD, Bazan-Peregrino M, Rifai B, et al. Cavitation-enhanced extravasation for drug delivery. Ultrasound Med Biol 2011;37(11):1838-52
78. Mehier-Humbert S, Yan F, Frinking P, et al. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem 2007;18(3):652-62 (Pubitemid 47010783)
79. Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun 2005;335(2):393-9 (Pubitemid 41140235)
80. Otani K, Yamahara K, Ohnishi S, et al. Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles. J Control Release 2009;133(2):146-53
81. Vandenbroucke RE, Lentacker I, Demeester J, et al. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J Control Release 2008;126(3):265-73
82. Endo-Takahashi Y, Negishi Y, Kato Y, et al. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound. Int J Pharm 2012;422(1-2):504-9
83. Negishi Y, Endo Y, Fukuyama T, et al. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J Control Release 2008;132(2):124-30
84. Aoi A, Watanabe Y, Mori S, et al. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol 2008;34(3):425-34 (Pubitemid 351625448)
85. Carson AR, McTiernan CF, Lavery L, et al. Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol 2011;37(3):393-402
86. Ogawa R, Morii A, Watanabe A, et al. Regulation of gene expression in human prostate cancer cells with artificially constructed promoters that are activated in response to ultrasound stimulation. Ultrason sonochem 2012;Epub ahead of print Available from: http://dx.doi.org/10.1016/j. ultsonch.2012.05.007
87. Park J, Elshami A, Amin K, et al. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ ganciclovirmediated gene therapy. Gene Ther 1997;4(9):909
88. Smith RR, Huebner RJ, Rowe WP, et al. Studies on the use of viruses in the treatment of carcinoma of the cervix. Cancer 1956;9(6):1211-18
89. Howard CM, Forsberg F, Minimo C, et al. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J Cell Physiol 2006;209(2):413-21 (Pubitemid 44484632)
90. Greco A, Di Benedetto A, Howard CM, et al. Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther 2009;18(2):295-306
91. Mannell H, Pircher J, Räthel T, et al. Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors. Pharm Res 2012;29(5):1282-94
92. Kirn D. Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials. Expert Opin Biol Ther 2001;1(3):525-38 (Pubitemid 33768667)
93. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release 2005;104(1):213-22 (Pubitemid 40615248)
94. Schlicher RK, Radhakrishna H, Tolentino TP, et al. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006;32(6):915-24 (Pubitemid 43903070)
95. Zhou Y, Kumon RE, Cui J, Deng CX. The size of sonoporation pores on the cell membrane. Ultrasound Med Biol 2009;35(10):1756-60
96. Kim HJ, Greenleaf JF, Kinnick RR, et al. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996;7(11):1339-46 (Pubitemid 26318673)
97. Stieger SM, Caskey CF, Adamson RH, et al. Enhancement of vascular permeability with low-frequency contrastenhanced ultrasound in the chorioallantoic membrane model1. Radiology 2007;243(1):112-21 (Pubitemid 46579701)
98. Bohmer M, Chlon C, Raju B, et al. Focused ultrasound and microbubbles for enhanced extravasation. J Control Release 2010;148(1):18-24
99. Oosterhof G, Cornel E, Smits G, et al. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 1997;32(1):91
100. Wu F, Wang ZB, Jin CB, et al. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound. Ultrasound Med Biol 2004;30(4):511-17 (Pubitemid 38581151)
101. Deckers R, Moonen CTW. Ultrasound triggered, image guided, local drug delivery. J Control Release 2010;148(1):25-33
102. Tagami T, Ernsting MJ, Li SD. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release 2011;152(2):303-9